Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twelve analysts that are currently covering the stock, MarketBeat.com reports. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $13.55.
IAS has been the subject of several recent analyst reports. Wall Street Zen raised shares of Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Barclays raised their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the stock an "equal weight" rating in a report on Friday, August 8th. Stifel Nicolaus lifted their price target on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Finally, Raymond James Financial dropped their target price on Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating on the stock in a report on Friday, August 8th.
Get Our Latest Stock Report on IAS
Insider Transactions at Integral Ad Science
In related news, CEO Lisa Utzschneider sold 9,922 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $8.12, for a total transaction of $80,566.64. Following the transaction, the chief executive officer directly owned 380,557 shares of the company's stock, valued at approximately $3,090,122.84. The trade was a 2.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In the last three months, insiders have sold 35,073 shares of company stock valued at $289,641. Company insiders own 2.00% of the company's stock.
Hedge Funds Weigh In On Integral Ad Science
A number of hedge funds have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company grew its holdings in shares of Integral Ad Science by 3.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 41,678 shares of the company's stock worth $346,000 after purchasing an additional 1,195 shares in the last quarter. Teacher Retirement System of Texas lifted its position in Integral Ad Science by 14.6% during the second quarter. Teacher Retirement System of Texas now owns 13,625 shares of the company's stock worth $113,000 after purchasing an additional 1,739 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Integral Ad Science by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,326 shares of the company's stock worth $349,000 after purchasing an additional 1,807 shares during the period. Envestnet Asset Management Inc. grew its stake in Integral Ad Science by 7.4% during the fourth quarter. Envestnet Asset Management Inc. now owns 31,807 shares of the company's stock worth $332,000 after buying an additional 2,188 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in Integral Ad Science by 547.1% in the 1st quarter. GAMMA Investing LLC now owns 3,313 shares of the company's stock valued at $270,000 after buying an additional 2,801 shares during the period. Institutional investors own 95.78% of the company's stock.
Integral Ad Science Price Performance
Shares of NASDAQ IAS traded down $0.2050 during mid-day trading on Friday, hitting $9.0950. The company had a trading volume of 250,492 shares, compared to its average volume of 1,024,637. The firm has a market cap of $1.51 billion, a P/E ratio of 26.72, a PEG ratio of 1.32 and a beta of 1.57. The business's 50-day simple moving average is $8.31 and its 200-day simple moving average is $8.45. Integral Ad Science has a 12 month low of $6.26 and a 12 month high of $13.62.
Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. The firm had revenue of $149.20 million for the quarter, compared to analysts' expectations of $143.02 million. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, sell-side analysts predict that Integral Ad Science will post 0.26 EPS for the current year.
About Integral Ad Science
(
Get Free Report)
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Featured Stories

Before you consider Integral Ad Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integral Ad Science wasn't on the list.
While Integral Ad Science currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.